This article is the latest in the Health Affairs Forefront series, Provider Prices in the Commercial Sector, featuring analysis and discussion of physician, hospital, and other health care provider ...
The current generation of deals, which is likely to involve AbbVie (NYSE: ABBV), Merck & Co Inc (NYSE: MRK), Bristol-Myers Squibb Co (NYSE: BMY), and Gilead Sciences Inc (NYSE: GILD), is focused on ...
For more than two decades, federal and state lawmakers have tried to prod, even force, health care providers to list their prices. Congress has passed a few laws targeting hospitals, but many haven’t ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results